ENGENE THERAPEUTICS INC

Historical 13F Holders

Symbol
ENGN
CUSIP
29286X101
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 29286X101 since 12/18/2024, largest first.

Filer % of Class Filed
Invus Global Management, LLC 13G/A
9.3% 8/13/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Blue Owl Capital Holdings LP 13G/A 0.8% 8/12/2026
Event 6/30/2026
Deep Track Capital, LP 13G/A
0% 8/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 100 $200.00
2026 Q2 62 38.5 M $66.6 M
2026 Q1 2 344 k $2.34 M